BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19234147)

  • 21. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo.
    Nickoloff BJ; Mitra RS; Lee K; Turka LA; Green J; Thompson C; Shimizu Y
    Am J Pathol; 1993 Apr; 142(4):1029-40. PubMed ID: 7682758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease.
    Green JM
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):261-4. PubMed ID: 10696061
    [No Abstract]   [Full Text] [Related]  

  • 23. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.
    Manzotti CN; Liu MK; Burke F; Dussably L; Zheng Y; Sansom DM
    Eur J Immunol; 2006 Jun; 36(6):1413-22. PubMed ID: 16708397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of experimental glomerulonephritis by interference with T- or B-cell activation signals or adhesion molecules.
    Andres G; Nishikawa K; Stamenkovic I; McCluskey RT
    Adv Nephrol Necker Hosp; 1995; 24():91-105. PubMed ID: 7572424
    [No Abstract]   [Full Text] [Related]  

  • 26. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
    Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
    Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.
    Afek A; Harats D; Roth A; Keren G; George J
    Exp Mol Pathol; 2004 Jun; 76(3):219-23. PubMed ID: 15126104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.
    Lando PA; Dohlsten M; Hedlund G; Brodin T; Sansom D; Kalland T
    Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.
    Sansom DM; Wilson A; Boshell M; Lewis J; Hall ND
    Immunology; 1993 Oct; 80(2):242-7. PubMed ID: 7505258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcellular localization of CD80 receptors is dependent on an intact cytoplasmic tail and is required for CD28-dependent T cell costimulation.
    Doty RT; Clark EA
    J Immunol; 1996 Oct; 157(8):3270-9. PubMed ID: 8871621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SnapShot: B7/CD28 costimulation.
    Paterson AM; Vanguri VK; Sharpe AH
    Cell; 2009 May; 137(5):974-4.e1. PubMed ID: 19490900
    [No Abstract]   [Full Text] [Related]  

  • 33. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation.
    Muraille E; De Smedt T; Thielemans K; Urbain J; Moser M; Leo O
    Cell Immunol; 1995 May; 162(2):315-20. PubMed ID: 7538050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E; McGuire K; Hedlund G; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD28/B7 system of T cell costimulation.
    Lenschow DJ; Walunas TL; Bluestone JA
    Annu Rev Immunol; 1996; 14():233-58. PubMed ID: 8717514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell receptor stimulation, but not CD28 costimulation, is dependent on LFA-1-mediated events.
    Green JM; Zheng XG; Shimizu Y; Thompson CB; Turka LA
    Eur J Immunol; 1994 Jan; 24(1):265-72. PubMed ID: 7517362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.
    Edmead CE; Patel YI; Wilson A; Boulougouris G; Hall ND; Ward SG; Sansom DM
    J Immunol; 1996 Oct; 157(8):3290-7. PubMed ID: 8871623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.
    del Rio ML; Penuelas-Rivas G; Dominguez-Perles R; Ramirez P; Parrilla P; Rodriguez-Barbosa JI
    Eur J Immunol; 2005 Dec; 35(12):3545-60. PubMed ID: 16285013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
    Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
    Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.